Current Medical Diagnosis & Treatment, 2006 (Current Medical Diagnosis and Treatment)
Tierney, Lawrence M., McPhee, Stephen J., Papadakis, Maxine A.
Current Medical Diagnosis & Treatment, 45th Edition
document.getElementById('working').innerHTML = ''; function hide_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#fff'; e.style.scrollbarArrowColor = '#fff'; e.style.scrollbarDarkShadowColor = '#fff'; e.style.scrollbarShadowColor = '#fff'; } function show_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#ccc'; e.style.scrollbarArrowColor = '#000'; e.style.scrollbarDarkShadowColor = '#000'; e.style.scrollbarShadowColor = '#666'; } function toggle_CA(e) { var src; src = window.parent.getSrc(e); if (src.nextSibling.style.display == 'block') { src.nextSibling.style.display='none'; src.innerHTML='View Answer'; } else { src.nextSibling.style.display='block'; src.innerHTML='Hide Answer'; } } function resolve_link(e,setid,locator,dbid,toan) { e.href = "ovidweb.cgi?S=IDNJHKIDOHDOJK00D;FTS+Link+Set+Ref=" + setid + "|" + locator + "|" + dbid + "|" + toan; return true; }
L
L-AmB See Liposomal amphotericin B
L (cell wall-deficient) forms, penicillin resistance and
1560
L/S ratio See Lecithin/sphingomyelin (L/S) ratio
La belle indiff rence
1048
La/SSB antibody
836
in Sj gren's syndrome
836
842–843
Labetalol, for hypertension
431
in pregnancy
416–417
urgencies/emergencies
442–445
443
Labor and delivery
for acute fatty liver of pregnancy
779
for cardiac patient
417
for diabetic patient
777
herpes simplex transmission during
1351
induction of, after 41 weeks
766
preeclampsia/eclampsia and
771
772
773
preterm (premature), prevention of
783–784
Laboratory reference ranges, for diagnostic/laboratory tests See also Diagnostic/laboratory tests
Laboratory tests See Diagnostic/laboratory tests
Labyrinthectomy, for vertigo
193
Labyrinthine concussion, vertigo caused by
191
Labyrinthitis
191
Lacerations
cerebral
1020
ocular
171–172
Lac-Hydrin
90
Lacrimal apparatus, disorders of
154–155
Lacrimal sac, infection of (dacryocystitis)
155
Lacrosse agent, California encephalitis caused by
1371
b-Lactam antibiotics See Beta-lactam antibiotics
b-Lactamases See Beta-lactamases
Lactase deficiency (lactose intolerance)
600
606–607
diarrhea caused by
549
606
flatus caused by
545
606
Lactase enzyme replacement
607
Lactate See Lactic acid
Lactate dehydrogenase (LDH)
ascitic fluid
560
561
in hemolytic-uremic syndrome
490
522
laboratory reference range for
1739
in microangiopathic hemolysis
490
in non-Hodgkin's lymphoma
513
in paroxysmal nocturnal hemoglobinuria
491
in pneumocystis pneumonia
1322–1323
1541
in preeclampsia-eclampsia
772
in shock liver (ischemic hepatopathy)
680
in testicular cancer
972
in thrombotic thrombocytopenic purpura
490
521
in vitamin B12 deficiency
488
Lactated Ringer's solution See Fluid management/hydration
Lactation/breast feeding
784–787
785–786
antidepressant use and
785
1070
breast abscess and
704
787
breast cancer and
716
782
drug/medication use/avoidance during
785–786
See also specific agentHIV infection/AIDS transmission and
776
1333
iron needs during
482
IUD insertion and
755
mastitis and
787
nutrition requirements in
784–785
1254
1256
1257
oral contraceptive use and
753
oxytocin deficiency affecting
1110
progestin minipill and
753
prolactin in
1113
suppression of
785–787
tuberculosis treatment and
262
Lactic acid (lactate)
formation of
887
laboratory reference range (normal value) for
887
1740
in lactic acidosis
887
1233
Lactic acidosis
887
1228
1233
alcoholic ketoacidosis and
888
metformin causing
1210
1212
Lactose (milk) intolerance
600
606–607
diarrhea caused by
549
606
flatus caused by
545
606
Lactulose
for constipation
543
544
for hepatic encephalopathy
672
bleeding esophageal varices and
575
Lacunar infarction
456
991
992
See also StrokeLADA See Latent autoimmune diabetes mellitus of adulthood
Laennec's cirrhosis
668
Lambert-Eaton (myasthenic) syndrome
1035
in cancer
268
1005
1035
1696
Lamin A/C gene, in familial partial lipodystrophy
1098
Laminectomy, decompressive
for cancer-related cord compression
1689
for spinal trauma
1021
Lamisil See Terbinafine
Lamivudine (3TC)
1337
1340
1342
1343
1352
1588
See also Antiretroviral therapywith abacavir
1340
1343
for hepatitis B
660
1352
1588
resistance to
1344
1344
with zidovudine
1339
1343
postexposure
1333
with zidovudine and abacavir
1340
1343
Lamotrigine
984
for bipolar disease
1078
for seizures
983
984
Lange-Nielsen syndrome
381
Langerhans cell histiocytosis
1104
1107
Language
assessment of in mental status exam
1038
1039
in schizophrenia/psychotic disorders
1057
stroke affecting
991
Lanreotide, for acromegaly/gigantism
1111–1112
Lansoprazole
588
See also Proton pump inhibitorsLantus See Insulin glargine
LAP See Leukocyte alkaline phosphatase
Laparoscopy
in ascites
560
in ectopic pregnancy
770
in gynecologic disorders
729
in infertility workup
749
in pelvic inflammatory disease
742
Lapatanib (GW572016)
1699
Lapdap (proguanil plus dapsone)
1488
Large cell carcinoma of lung
267
See also Lung cancerLarge-needle (core needle) biopsy, for breast lump evaluation
711–712
711
712
See also Breast, biopsy ofLarge-volume paracentesis
for cirrhotic ascites
670–671
for peritoneal carcinomatosis
562
Larva currens, in strongyloidiasis
1530
Larva migrans
cutaneous
1519
visceral (toxocariasis)
1534–1535
Laryngeal height, obstructive airway disease diagnosis and
23
23
Laryngeal leukoplakia
210
Laryngeal nerve, recurrent
damage to during thyroid surgery
1126
1140
vocal cord paralysis caused by lesions of
213
Laryngeal papillomas
209–210
Laryngectomy, for squamous cell carcinoma of larynx
211–212
Laryngitis
210
Laryngopharyngeal reflux See also Gastroesophageal reflux disease
hoarseness and
210
566
Laryngospasm
antipsychotic drugs causing
1064
in drowning
1601
1602
in hypocalcemia
878
Larynx
209–213
tumors of
210–212
212
LASEK See Laser epithelial keratomileusis
Laser epithelial keratomileusis (LASEK)
153
Laser-induced prostatectomy (TULIP), for benign prostatic hyperplasia
960–961
Laser in situ keratomileusis (LASIK)
153
Laser therapy
for acne scars
117
for age-related macular degeneration
165
for angina
351
for benign prostatic hyperplasia
960–961
for burn reconstruction
1598
for cervical intraepithelial neoplasia/cervical cancer
735
for condylomata acuminata
128–129
733
for coronary revascularization
351
for diabetic retinopathy
167
1221
for esophageal cancer palliation
578
for glaucoma
161
P.1821
for hair removal, in pseudofolliculitis
119
lifestyle changes in prevention of
1646
for lung cancer palliation
271
for refractive errors
153–154
for wart removal
128–129
Laser transmyocardial revascularization
351
LASIK See Laser in situ keratomileusis
Lasix See Furosemide
Lassa fever
1376
Latanoprost, for glaucoma/intraocular hypertension
161
173
Latanoprost/timolol, for glaucoma/intraocular hypertension
161
174
Late life psychosis
1057
1094
1095
Latent autoimmune diabetes mellitus of adulthood (LADA)
1195
Latent deviation (phoria)
152
Lateral epicondylitis
824
Lateral femoral cutaneous nerve lesions (meralgia paresthetica)
1029
Lateral sclerosis
amyotrophic See Amyotrophic lateral sclerosis
primary
1022
Latex agglutination (LA) antigen tests
800
Latex allergy
114
Latrodectus mactans
136
1636
Laurence-Moon-Bardet-Biedl syndrome
1098
Lavage
bronchoalveolar See Bronchoalveolar lavage
gastric, for poisoning/drug overdose
1611–1612
Lavender top tubes
1743
Law of similars, in homeopathy
1729
Laxative abuse
1090
in bulimia nervosa
1271
diarrhea caused by
549
screening for
549
Laxatives
543–544
543
for irritable bowel syndrome
617
LCHAD deficiency, in acute fatty liver of pregnancy
779
780
LCIS See Lobular carcinoma in situ
LCM See Lymphocytic choriomeningitis
LCR assay See Ligase chain reaction (LCR) assay
LDCT See Low-dose helical computed tomography
LDL See Low-density lipoproteins
Lead, laboratory reference range for
1740
Lead encephalopathy
1626
1627
gasoline sniffing and
1090
Lead nephropathy
926
927
Lead poisoning
1611
1626–1627
gout and
812
926
ocular effects of
179
sideroblastic anemia caused by
486
tubulointerstitial disease caused by
926
927
Lecithin, in gallstones
684
Lecithin/sphingomyelin (L/S) ratio, laboratory reference range for
1740
Leflunomide, for rheumatoid arthritis
803
804
832
Left heart catheterization
317–318
See also Cardiac catheterizationLeft heart failure (left ventricular failure/dysfunction)
386
See also Congestive heart (cardiac) failurein hypertension
424–425
in myocardial infarction
362–363
preoperative evaluation/management of patient with
39–40
Left-to-right shunts See also Shunts
in atrial septal defect
321
in ventricular septal defect
322
Left ventricular aneurysm, myocardial infarction and
364
Left ventricular angiography
347
Left ventricular dysfunction See Left heart failure
Left ventricular end-diastolic pressure, in dyspnea
23
24
Left ventricular hypertrophy
in cardiomyopathy
402
403
hypertensive
424–425
426
sudden death in athletes and
418
Leg See also under Lower extremity
appearance of
in varicose veins
469
in venous insufficiency
473–474
Leg cramps, nocturnal
1102
Leg pain See also Claudication
in pulmonary embolism
282
Leg ulcers, in venous insufficiency/varicose veins/lower extremity occlusive disease
141–142
453
469
474
Legal blindness
150
diabetic retinopathy and
167
1221
Legal issues
in end-of-life care
69
herbal medicine regulation and
1710
Legionella pneumophila
1423
1553
Legionnaire's disease (legionella pneumonia/legionellosis)
249
251
252
254
255
1423
1553
1556
Leiden mutation (factor V Leiden)
532
pulmonary embolism and
281
Leiomyomas
gastrointestinal See Stromal tumors
of uterus (fibroid tumor)
737–738
Leiomyosarcoma
gastrointestinal See Stromal tumors
of uterus
737
Leishman-Donovan bodies
1480
Leishmania (leishmaniasis)
1480–1486
aethiopica
1480
1481
1484
amazonensis
1480
1483
1484–1485
braziliensis
1481
1485
chagasi
1480
1483
1485
coinfections and
1481
cutaneous
1480
1481
1484–1485
diffuse
1481
1484
New World
1480
1484–1485
Old World
1480
1484
post-kala azar
1483
donovani
1480
1483
1484
guyanensis
1485
infantum
1480
1483
1484
major
1480
1484
mexicana
1480
1483
1484
mucocutaneous (espundia)
1480–1481
1485–1486
panamensis
1481
1484
1485
peruviana
1485
post-kala azar dermal
1483
recidivans
1484
tropica
1480
1483
1484
viannia group
1481
1485
visceral (kala azar)
1480
1482–1484
Leishmanin skin test
1481
1483
1485
Lemierre's syndrome
207
1435
Lenalidomide (CC-5013/revlimid)
1668
1699
for myelodysplasia
507
for myelofibrosis
504
for myeloma
516
Lens opacity See Cataract
Lente insulin
1212
1213
1214
1214
See also Insulin therapyin mixtures
1215
Lentigines
93
143
in endocrine disorders
1100
solar (liver spots)
93
143
Lentigo maligna melanoma
94
Leprechaunism
1195
1197
Lepromatous leprosy
1439
1440
neuropathy associated with
1025
Leprosy
1439–1440
1553
drug resistance in
1576
neuropathy associated with
1025
1439
sulfones for
1576–1577
Leptin, in obesity
1098
1268
insulin action and
1196
nonalcoholic fatty liver disease and
667
Leptomeningeal metastases (carcinomatous meningitis)
1001
1690
Leptospira autumnalis/canicola/icterohaemorrhagiae/interrogans/pomona (leptospirosis)
1455–1456
1554
Leriche's syndrome
453
1101
Lescol See Fluvastatin
Lethal midline granuloma
201
Lethal toxin/factor, anthrax
1411
Letrozole
721
1670
1673
Leucovorin (folinic acid) rescue
with methotrexate
831
1677
1684
with pyrimethamine
1575
with trimetrexate
1575
Leukemias
acute
507–510
See also specific typelymphoblastic/lymphocytic (ALL)
508
509
1663
megakaryoblastic
508
monoblastic
508
myeloblastic
508
myelogenous/myeloid
508
509
1663
myelomonocytic
508
1663
promyelocytic
508
undifferentiated
508
aleukemic
508
chromosomal abnormalities in
504
chronic
lymphocytic (CLL)
510–511
1641
1663
myelogenous/myeloid (CML)
500
504–506
1641
1663
myelomonocytic (CMML)
504
506
507
prolymphocytic
510
in Down's syndrome
1704
fever/FUO and
1287
hairy cell
511–512
1663
HPC transplants for
505–506
509
511
803
incidence/mortality of
1640
plasma cell
515
rheumatic manifestations of
863
secondary to chemotherapy or radiation therapy
508
1601
1644–1645
1660
Leukemic arthritis
863
Leukoagglutinin transfusion reactions
534
leukopoor blood in prevention of
533
Leukocyte alkaline phosphatase
laboratory reference range for
1740
in paroxysmal nocturnal hemoglobinuria
491
Leukocyte casts
896
897
935
Leukocyte count See White blood cell count
Leukocyte esterase, in urine
935
Leukocytes
fecal, in diarrhea
547
550
pleural fluid
301
urinary
896
935
Leukocytosis
in antibiotic-associated (Clostridium difficile) colitis
619
in cellulitis
125
P.1822
lithium causing
1076
in lymphangitis/lymphadenitis
475
in toxocariasis (visceral larva migrans)
1534
Leukoderma
143
Leukoencephalitis, in Lyme disease
1459
Leukoencephalopathy, progressive multifocal (PML)
1324–1325
1375
Leukoerythroblastic blood, examination/morphology of
503
Leukoplakia
laryngeal
210
oral
202–203
in HIV infection/AIDS
216
217
1325
Leukopoor blood, transfusion of
533
Leukotriene modifiers
790
for allergic rhinitis
198
790
for asthma
233
234
Leuprolide
1674
See also Luteinizing hormone-releasing hormone (LHRH) analogsfor male infertility
1107
Levamisole
for ascariasis
1519
for hookworm disease
1526
Levaquin See Levofloxacin
Levatol See Penbutolol
Levetiracetam, for seizures
983
984
Levitra See Vardenafil
Levo-Dromoran See Levorphanol
Levobunolol, for glaucoma/intraocular hypertension
161
173
Levocabastine, for ophthalmic disorders
176
Levodopa
benzodiazepine interactions and
1046
monoamine oxidase inhibitor interactions and
1009
1074
for parkinsonism
1008–1009
with entacapone and carbidopa
1009
1010
Levofloxacin
1579
1580
1580
1581
cost of
1562
for tuberculosis
1575
Levonorgestrel
in combination oral contraceptives
751–752
for emergency contraception
757
in Mirena intrauterine device
755
in Norplant system
754
1187
Levorphanol
77
Levothyroxine (thyroxine)
for goiter
1131
for hypothyroidism/myxedema
1106
1133
during pregnancy
781
1133–1134
RAI therapy for thyroid cancer and
1126
1127
for thyroid nodules
1120
1121
after thyroidectomy
1126
Lewy bodies, dementia with
56
Lexapro See Escitalopram
Lexiva See Fosamprenavir
Leydig cell tumors/hyperplasia
971
1171
1180
1182
Lhermitte's sign
816
LHRH analogs See Luteinizing hormone-releasing hormone (LHRH) analogs
LHX3/LHX4 gene mutations, in pituitary hormone deficiency
1104
Libido, loss of
950
1053
1101
See also Sexual dysfunctionLibman-Sacks endocarditis, in systemic lupus erythematosus
834–835
Librium See Chlordiazepoxide
Lice
135–136
epidemic typhus transmitted by
1391–1393
1392
relapsing fever transmitted by
1454
trench fever transmitted by
1433
Lichen planus
131–132
drugs causing eruptions similar to
131
148
oral
202–203
Lichen planus-like drug eruptions
131
148
Lichen sclerosus, vulvar
739
Lichen simplex chronicus (circumscribed neurodermatitis)
97
Lichenoid eruptions, drugs causing
131
148
Licorice-induced hypokalemia
874
1173
Lid See Eyelids
Lid lag, in dysthyroid eye disease
170
Liddle's syndrome
874
874
1173
Lidex See Fluocinonide
Lidocaine
for arrhythmias
369
ventricular tachycardia
379
monitoring concentrations of
1734
Lidocaine patch, for postherpetic neuralgia/neuropathic pain
79
80
Lidoderm See Lidocaine patch
Lids See Eyelids
Life expectancy
approach to older patient and
49–50
median
50
Life support, withdrawal/withholding, in end-of-life care
69
82
83
Lifestyle
modifications of
in cancer prevention
1646–1648
in cardiac failure management
395
compliance with recommendations for
1
in disease prevention
12–13
in dyspepsia management
537
in gastroesophageal reflux management
568
in hypertension management/prevention
419
420
421
421
426–427
in elderly
54
sedentary
lipid abnormalities and
12
1244
prevention of
12–13
urinary stone formation and
944
Ligase chain reaction (LCR) assay, in chlamydial infection
1441
Light, pupillary reaction to
152
See also Pupillary reactionsLight chains, immunoglobulin, in urine See Bence Jones proteinuria
Light eruption, polymorphous
140
Light perception (visual acuity)
151
Light therapy See Phototherapy
Light visors, for depression with seasonal onset
1074
Lightning injuries
1599
Ligneous (Riedel's) thyroiditis
1145
1146
“Like cures like” principle
1729
Limb-girdle (Erb's) muscular dystrophy
1035–1036
1036
Limb ischemia
acute
461–462
in lower extremity occlusive disease
453
Limb loss See Amputation
Lindane, overdose/toxicity of
1622
Linear scleroderma
839
Linezolid
1579
for enterococcal infection
1403
1579
for staphylococcal skin infection
1406
Linitis plastica
597
Linoleic acid
1258
dietary reference intakes (DRIs) for
1257
in nutritional support
1282
α-Linolenic acid, dietary reference intakes (DRIs) for
1257
Lioresal, for spasticity
1016
Liothyronine See also Thyroid hormone
antidepressant drug augmentation and
1068
1073
Lipase
in digestion
601
in pancreatic enzyme supplements
699
serum levels of
laboratory reference range for
1740
in pancreatitis
694
698
Lipemia retinalis
1198–1199
1244
Lipid-based amphotericin B
1548
1550
1583
for cryptococcal meningitis
1543
for leishmaniasis
1481
1482
1483
1583
Lipid fractions See Lipoproteins
Lipid-lowering therapy
8–10
341
1242
1247–1252
1248
1251
for acute coronary syndromes
353
cancer prevention and
1653
in cardiovascular disease prevention
8–10
341
cholesterol screening and
1244–1247
1245–1246
in women and elderly
1246
1247
diet for
1247–1249
1278–1279
in diabetes
1203
1205
estrogen replacement therapy and
1187
in hypertriglyceridemia
1252
for myocardial infarction
353
365
nutrients affected by
1260
pharmacologic
1249–1252
1251
See also specific type of therapy and Statin drugsrhabdomyolysis/myopathy/myositis caused by
841
843
selection of medication for
1250
Lipid-modifying diet
1247–1249
1278–1279
in diabetes
1203
1205
Lipids
1240
See also Fat; Lipoproteinsabnormalities of metabolism of
1240–1252
in atherogenesis/coronary heart disease
339
340
1240–1241
1241–1242
in diabetes mellitus
1201
1243
1244
exercise/activity and
12
protease inhibitors causing
1340
secondary causes of
1243
1244
diet affecting
1247–1249
1278–1279
intravenous, in nutritional support
1282
1284
pharmacologic therapy affecting See also Lipid-lowering therapy
screening tests for levels of
3
1244–1247
1245–1246
Lipiduria
896
Lipitor See Atorvastatin
Lipoatrophic diabetes
1195
Lipodystrophy
familial partial
1098
at insulin injection sites
1221
protease inhibitors causing
1340
Lipohypertrophy, at insulin injection sites
1221
Lipoid nephrosis (minimal change disease)
920
Lipoid pneumonia
294
Lipomas
atrial septal
413
epidermal inclusion cysts differentiated from
139
intestinal
610
in multiple endocrine neoplasia
1150
Lipopolysaccharide, in burn injury
1596
Lipoprotein(a), estrogen replacement affecting
1187
P.1823
Lipoproteins
1240
See also specific type andCholesterol
atherogenesis/coronary heart disease and
339
340
1240–1241
1241–1242
in diabetes mellitus
1201
estrogen replacement affecting
1187
lowering
341
See also Lipid-lowering therapyscreening tests for levels of
1244–1247
1245–1246
testosterone replacement affecting
1182
Liposomal amphotericin B (AmBisome)
1548
1583
See also Lipid-based amphotericin Bfor leishmaniasis
1481
1482
1483
Liposomal daunorubicin
1066
1675
Liposomal doxorubicin
1666
1675
for Kaposi's sarcoma
1328
Liquid diets
1277–1278
Liquid nitrogen See also Cryotherapy
for condylomata acuminata
128
733
hypopigmentation and
143
for wart removal
128
Lisinopril
434
439
Lispro insulin See Insulin lispro
Listeria monocytogenes (listeriosis)
1414
1553
LITH gene, in cholelithiasis/gallstones
684
Lithium
1075–1077
1077
adverse ocular effects of
178
antidepressant drug augmentation and
1068
1073
1075–1076
antidepressant drug interactions and
1074
for bipolar disorder/mania
1075–1077
breast feeding and
785
drug interactions of
1074
1077
hypothyroidism and
1076
monitoring concentrations of
1076
1734
overdose/toxicity of
1076–1077
1615
hemodialysis for
1077
1613
seizures and
1610
in pregnancy
1076
RAI therapy of thyroid cancer and
1127
for unipolar depression
1075
Lithotomy, during pregnancy
782
Lithotripsy
for choledocholithiasis/cholangitis
689
for cholelithiasis/gallstones
686
for renal stones
947
for ureteral stones
947
Livedo reticularis
466
Liver
abscesses of
amebic
1468–1472
1471
pyogenic
680–681
biopsy of
650
in alcoholic liver disease
664
in cirrhosis
669
in hemochromatosis
677
in hepatic vein obstruction (Budd-Chiari syndrome)
679
in hepatocellular carcinoma
682
in nonalcoholic fatty liver disease
668
cancer of
681–683
cirrhosis and
657
670
681–682
683
hepatitis and
653
657–658
659
681
682
683
1644
paraneoplastic syndromes associated with
1696–1697
polyprenoic acid in prevention of
1649
cavernous hemangioma of
683
disorders of
652–684
See also specific disorder and under Hepaticacute hepatic failure
658–659
alcoholic
663–665
ascites in
558
559
559
spontaneous bacterial peritonitis and
560
561
671
biliary cirrhosis
670
674–676
bleeding associated with
528–529
cirrhosis
668–674
674
S-adenosylmethionine (SAMe) for
1719
1721
in clonorchiasis/opisthorchiasis
1506
coagulopathy
528–529
esophageal varices and
574
diagnosis of
650–652
651
drug- and toxin-induced
665–666
See also Hepatotoxicityesophageal varices in
573
574
in fascioliasis
1505
hemochromatosis
676–677
hepatitis
autoimmune
662–663
viral
652–658
chronic
659–662
in HIV infection/AIDS
1326
jaundice in
649–652
650
651
kava causing
1717
lipid abnormalities and
1244
neoplastic
681–684
See also Liver, cancer ofbenign tumors
683–684
drugs/toxins causing
666
oral contraceptive use and
683
753
nonalcoholic fatty liver disease
667–668
See also Fatty livernoncirrhotic portal hypertension
680
NSAIDs causing
830
parenteral nutritional support and
1284
preoperative evaluation/management of patient with
42–43
in syphilis
1450
tetracycline causing
1571
Wilson's disease
677–678
enlarged See Hepatomegaly
fatty See Fatty liver
fibrosis of
drugs/toxins causing
666
in fatty liver disease
668
focal nodular hyperplasia of
683
684
in heart failure
389
680
hydatid cyst of
1513
1514
1515
in schistosomiasis
1502
1503
shock
680
transplantation of
adenovirus infection and
1386
1387
for amatoxin-type mushroom poisoning
1630
for autoimmune hepatitis
663
for biliary cirrhosis
675
for cholangiocarcinoma
693
for cirrhosis
673
esophageal varices and
576
for hepatic failure
658
659
for hepatic vein obstruction (Budd-Chiari syndrome)
679
for hepatocellular carcinoma
682–683
for hepatopulmonary syndrome
673
for primary sclerosing cholangitis
692
for Wilson's disease
678
Liver cell adenoma See Hepatic adenoma
Liver failure See Hepatic (liver) failure
Liver flukes
Chinese, clonorchiasis caused by
1506
sheep, fascioliasis caused by
1505
Liver function tests
650
651
Liver-kidney microsomes, antibody to, in autoimmune hepatitis
663
Liver spots (solar lentigines)
93
143
Livial See Tibolone
Living will (advance directives)
70
Livostin See Levocabastine
LMW (low-molecular-weight) heparin See Heparin
Loa loa (loiasis)
1526–1527
Lobectomy, pulmonary
for hydatid cysts
1514
for lung cancer
271
Lobular carcinoma in situ
713
716
716
Local anesthetics, for eye disorders, precautions for use of
177
Locked-in syndrome (de-efferented state)
1019
Lodine See Etodolac
Lodoxamide, for ophthalmic disorders
175
L ffler's syndrome
404
ascariasis and
1518
Logiparin See Tinzaparin
logMar (EDTRS) chart, for visual acuity testing
151
Loiasis
1526–1527
Lomustine (CCNU)
1672
“Lone atrial fibrillation”
375
376
Lone Star tick See Ticks
Long-acting insulin
1212
1215
1218
See also Insulin therapyLong QT syndrome
381–382
See also QT interval, longLong-term care facilities, tuberculosis/tuberculosis testing in elderly and
55
257
Loniten See Minoxidil
Loop diuretics See also Diuretics; Furosemide
for acute tubular necrosis
904
for cardiac failure
391
renal failure and
391
910
for hyperkalemia
877
for hypernatremia
872
for hypertension
428
429
urgencies/emergencies
445
Loop resection, for cervical intraepithelial neoplasia
735
Loperamide
547
551
See also Antidiarrheal agentsfor irritable bowel syndrome
617
Lopid See Gemfibrozil
Lopinavir/r (lopinavir/ritonavir)
1338
1341
1342
1343
See also Antiretroviral therapyresistance to
1345
Lopressor See Metoprolol
Loprox See Ciclopirox
Lorabid See Loracarbef
Loracarbef
1566
cost of
1562
Loratadine
789
See also AntihistaminesLorazepam
1044
1045
1045
1079
See also Benzodiazepinesfor anxiety/stress disorders
1042
1044
1045
for nausea and vomiting
540
1682
for seizures, status epilepticus and
986
Lorazepam interview, in conversion disorder
1049
Lorcet See Hydrocodone
Lorenzo's oil
1167
Lortab See Hydrocodone
Losartan
433
434
with hydrochlorothiazide
435
Lotensin See Benazepril
Lotrimin Ultra See Butenafine
Louse See Lice
Lovastatin
1242
1250
1251
See also Statin drugsLovenox See Enoxaparin
P.1824
Low back pain
817–819
819
See also Back painLow carbohydrate diets
cholesterol profile affected by
340
in obesity management
1099
1268
Low-cholesterol diet
1247–1248
1278–1279
Low-density lipoproteins
1240
atherogenesis/coronary heart disease and
339
340
1240–1241
1241–1242
in diabetes mellitus
1201
diet affecting
1147–1148
laboratory reference range (normal values) for
1740
lowering levels of
8–10
341
1242
1247–1252
1248
1251
See also Lipid-lowering therapycholesterol screening and
1244–1247
in women and elderly
1246
1247
rosiglitazone affecting levels of
1210
screening tests for levels of
1244–1247
Low-dose helical computed tomography (LDCT), in lung cancer screening
265
Low-fat diet
1278
1278–1279
in cancer prevention
1647
1648
diabetes prevention/management and
1203
1205
for pancreatitis
696
698
Low-molecular-weight heparin See Heparin
Low-salt diet See Sodium-restricted diet
Low-saturated-fat diet
1279–1280
Low-sodium diet See Sodium-restricted diet
Lower airway/respiratory tract disorders
225–226
See also PneumoniaLower esophageal sphincter See Esophageal sphincter, lower
Lower extremity edema
24–26
25
in chronic venous insufficiency
24–26
25
473
leg ulcers and
141
474
in heart disease
315–316
in pulmonary disease
222
Lower extremity occlusive disease
453–456
leg ulcers and
141
453
limb ischemia and
461–462
Lower gastrointestinal bleeding
554–557
See also Gastrointestinal bleedingLower motor neuron lesions, weakness in
988
Lown-Ganong-Levine syndrome
374
Loxapine
1059
1060
1060
Loxitane See Loxapine
Loxosceles
laeta
136
reclusa
136
1636
Lozol See Indapamide
LP See Light perception
LSD
1087
1627
Lubriderm
90
Ludiomil See Maprotiline
Ludwig's angina
207
Lues maligna
1450
Lumbar motion, Schober's test of
818
Lumbar puncture See also Cerebrospinal fluid analysis
headache after
978
in intracranial mass lesions, herniation syndromes and
1002
Lumbar spine/disk disease See also Spine
herniated disk
817
818
818
819
stenosis
819–820
tuberculosis (Pott's disease)
860
Lumbosacral plexus lesions
1031
Lumefantrine with artemether (Riamet)
1495
Lumigan See Bimatoprost
Luminous hallucinations, in migraine headache
975
Lump (breast)
709
710
See also Breast cancerbiopsy in evaluation of
710–712
711
712
clinical examination in detection/evaluation of
15
707
709–710
709
710
1654–1655
1655
cytology in evaluation of
711
711
712
713
differential diagnosis of
713
fat necrosis causing
704
fibroadenoma
703
in fibrocystic condition
702
in male
726
mammography in detection/evaluation of
14
15
707–708
708–709
711
712
in postmenopausal women
712
in premenopausal women
711
removal of See Lumpectomy
self-examination in detection/evaluation of
14
15
708
1655
ultrasonography in evaluation of
711
712
713
Lumpectomy
717–718
1658
local recurrence and
725
recommendations regarding
718
timing of, menstrual cycle and
717
Lunelle
754
Lung
218–311
See also under Pulmonary and Respiratoryabscess of
255
anaerobic
255
1434
aspergilloma of
1544
cancer of See Lung cancer
collapse of See Atelectasis
common manifestations of disease of
218–220
examination of
220–222
in heart disease
314–315
fibrosis of, in interstitial (diffuse parenchymal) diseases
275
hydatid cyst of
1513
1514
1515
radiation injury of
298–299
toxic/chemical injury of
297
1617
aspiration and
294
295
drug-induced
298
298
smoke inhalation and
294
1596
Lung biopsy
in interstitial (diffuse parenchymal) lung disease
276
in pulmonary infiltrates in immunocompromised host
256
in sarcoidosis
279
in solitary pulmonary nodule
266
Lung cancer
265–275
beta-carotene and vitamin E in prevention of
1650
1651
bronchogenic carcinoma
266–272
cough in
21
267
environmental/industrial carcinogens and
267
297
gene expression profiles in
1642
hemoptysis in
220
incidence/risk/mortality of
266–267
1639
1640
myasthenic syndrome in
268
1035
paraneoplastic syndromes associated with
267–268
1696–1697
pleural effusion in
302
radon exposure and
267
297
1601
screening for
265
1655
1656
secondary
272–273
smoking/smoking cessation and
267
297
1646
1647
solitary pulmonary nodule
265–266
staging of
268–270
269
270
survival rates for
272
272
treatment of
270–272
1664
Lung capacity
222
223
See also Pulmonary function teststotal (TLC)
223
in COPD
238
Lung fluke, paragonimiasis caused by
1506–1508
Lung scanning
in pulmonary embolism
282–283
in pulmonary heart disease
412
in pulmonary hypertension
291
Lung sounds
221
Lung transplantation
for COPD
242
for cystic fibrosis
246
for pulmonary hypertension
411
Lung volume reduction surgery (LVRS), for COPD
242–243
Lung volumes
221
222
223
See also Pulmonary function testsin COPD
238
Lupus anticoagulant
532–533
835
837
pregnancy loss and
775
776
837
stroke and
993
in systemic lupus erythematosus
532
835
836
Lupus anticoagulant-anticardiolipin-antiphospholipid antibody syndrome
775–776
837–838
See also Antiphospholipid syndrome/antiphospholipid antibodiespregnancy loss and
775
776
837
systemic lupus erythematosus and
835
836
836
Lupus cerebritis
836
Lupus erythematosus
autoantibodies in
105
799
834
835
836
chilblain
1591
chronic cutaneous
104–105
discoid
104–105
drug-related
105
147
298
793
834
834
subacute cutaneous (SCLE)
105
systemic
833–837
See also Systemic lupus erythematosusLupus nephritis
835
916
924
Lupus panniculitis
137
Luteinizing hormone (LH)
in amenorrhea
1184
deficiency of
1104–1105
1179
See also Hypogonadismgynecomastia and
1100
in hypogonadism
1179
1180
1180
1181
in infertility workup
749
953
954
laboratory reference range for
1740
for male infertility
954
in menopause
760
in persistent anovulation (polycystic ovary syndrome)
746
Luteinizing hormone-releasing hormone (LHRH) analogs
for benign prostatic hyperplasia
955
for prostate cancer
966
966
Luteinizing hormone-releasing hormone (LHRH) antagonists, for psychosexual disorders
1054
Luteoma of pregnancy
1171
Lutzomyia, leishmaniasis transmitted by
1480
Luvox See Fluvoxamine
LVEDP See Left ventricular end-diastolic pressure
LVRS See Lung volume reduction surgery
P.1825
Lyme disease (Lyme borreliosis)
1457–1462
1461
1554
arthritis in
1459
1461–1462
1461
Lyme disease vaccine and
1461
rheumatoid arthritis differentiated from
828
“chronic” (“post-Lyme disease syndrome”)
1461
1462
coinfections and
1462
ehrlichiosis
1397
1462
congenital
1458
diagnosis/overdiagnosis of
1457
1462
laboratory findings and
1459–1460
erythema migrans in
123–124
1458
head and neck symptoms in
216
HLA in
1459
myopericarditis in
408
1458
neuropathy associated with
1026
1458–1459
1459
during pregnancy
1458
1462
prevention of
1460–1461
serologic testing in
1459–1460
serosurveys in
1458
treatment of
1461–1462
1461
Lyme disease-like illness, Lone Star tick (Amblyomma americanum) in transmission of
1457
Lyme disease vaccine, removal of from market
1461
LYMErix See Lyme disease vaccine
Lymph, in urine (chyluria)
932
in filariasis
1522
Lymph nodes See also specific nodes and Lymphadenitis; Lymphadenopathy
in filariasis
1522
in Hodgkin's disease
514
Lymphadenectomy, selective (sentinel lymph node biopsy)
in breast cancer
718
1658
arm edema avoidance and
725
Lymphadenitis
475–476
in chancroid
1433
dermatopathic
106
in filariasis
1522
histiocytic necrotizing (Kikuchi's disease)
215
mycobacterial (tuberculous and nontuberculous)
215–216
1438
in plague
1431
Lymphadenopathy
in African trypanosomiasis
1463
autoimmune
215
in cat-scratch disease
1433
cervical, reactive
215
in chronic lymphocytic leukemia
510
in cutaneous T cell lymphoma (mycosis fungoides)
106
dermatopathic
106
in exfoliative dermatitis/erythroderma
106
in filariasis
1522
HIV
215
217
auditory tube dysfunction/serous otitis media and
194
in lymphogranuloma venereum (buboes)
645
1440
in non-Hodgkin's lymphoma
512
in onchocerciasis
1528
in pharyngitis
205
in Whipple's disease
604
Lymphangiosarcoma
476
Lymphangitic carcinomatosis
273
Lymphangitis
475–476
1556
in filariasis
1522
Lymphatic channel diseases
475–477
in filariasis
1522
in sporotrichosis
1546
Lymphedema
476–477
after mastectomy
477
Lymphedema praecox
476
Lymphedema tarda
476
Lymphoblastic lymphoma
513
Lymphocyte count
laboratory reference range for
1740
in nutritional assessment
1263
Lymphocytic choriomeningitis
1372–1374
Lymphocytic colitis
631
Lymphocytic gastritis
585
Lymphocytoma, borrelia
1458
Lymphocytopenia, idiopathic CD4
Lymphocytosis, in chronic lymphocytic leukemia
510
Lymphogranuloma venereum
645
1440–1441
Lymphoma
512–518
1663
See also Burkitt's lymphoma; Hodgkin's disease; Non-Hodgkin's lymphomaadult T cell
1375
See also Human T cell lymphotropic/leukemia virusin celiac disease
603
611
cerebral, primary, in HIV infection/AIDS
1000
1003
1324
1328
cutaneous T cell (mycosis fungoides)
105–106
1663
exfoliative dermatitis and
106
107
fever caused by
1287
follicular, bcl-2 gene in
512
gastric
598–599
Helicobacter pylori infection and
584
588–589
1644
gastrointestinal
610–611
head and neck
216
in HIV infection/AIDS
1000
1003
1323
1328
1335
1644
incidence/mortality of
1640
large cell (Richter's syndrome)
510
lymphoblastic
513
mantle cell
531
mucosa-associated lymphoid tissue (MALToma)
513
598–599
Helicobacter pylori infection and
584
598–599
1644
of thyroid
1124
1127
1129
nose and paranasal sinus involvement and
201
paraneoplastic syndromes associated with
1696–1697
primary effusion (body cavity)
1362
testicular
971
973
of thyroid
1124
1129
Lymphoproliferative disorder, posttransplant
1359
Lysergic acid diethylamide (LSD)
1087
1627